Francesco Pallone

Francesco Pallone's AcademicInfluence.com Rankings

Francesco Pallone

Biology

#9843

World Rank

#13094

Historical Rank

Biotechnology

#130

World Rank

#132

Historical Rank

Immunology

#597

World Rank

#617

Historical Rank

Molecular Biology

#1373

World Rank

#1400

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Francesco Pallone Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Francesco Pallone's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cutting Edge: TGF-β Induces a Regulatory Phenotype in CD4+CD25− T Cells through Foxp3 Induction and Down-Regulation of Smad7 (2004) (1269)
Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. (1997) (597)
Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. (2011) (441)
Bioactive IL-18 expression is up-regulated in Crohn's disease. (1999) (424)
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth (2014) (387)
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease. (2015) (304)
Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease. (2005) (297)
IL-21 Counteracts the Regulatory T Cell-Mediated Suppression of Human CD4+ T Lymphocytes1 (2007) (288)
Up-Regulation of IL-17 Is Associated with Bioactive IL-8 Expression in Helicobacter pylori-Infected Human Gastric Mucosa1 (2000) (271)
Regulation of gut inflammation and th17 cell response by interleukin-21. (2008) (258)
IL‐23/IL‐17 axis in IBD (2010) (250)
Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. (1999) (249)
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis (2009) (203)
Oral mesalazine (5‐aminosalicylic acid; Asacol) for the prevention of post‐operative recurrence of Crohn's disease (1994) (199)
IL‐21 regulates experimental colitis by modulating the balance between Treg and Th17 cells (2007) (192)
Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. (1987) (190)
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 (2006) (187)
Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis. (2006) (186)
The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study. (1988) (179)
Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers. (1991) (177)
Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease (2007) (171)
Cytokines: from gut inflammation to colorectal cancer. (2008) (169)
Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. (2009) (166)
IL‐23‐mediated regulation of IL‐17 production in Helicobacter pylori‐infected gastric mucosa (2008) (165)
A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells. (2007) (154)
Infliximab and newly diagnosed neoplasia in Crohn’s disease: a multicentre matched pair study (2005) (151)
Intra‐oesophageal distribution and perception of acid reflux in patients with non‐erosive gastro‐oesophageal reflux disease (2003) (150)
A Failure of Transforming Growth Factor-β1 Negative Regulation Maintains Sustained NF-κB Activation in Gut Inflammation* (2004) (150)
Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. (1995) (139)
Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis. (1996) (137)
Immunoregulation in the gut: success and failures in human disease (2002) (137)
Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis. (1998) (134)
A novel diagnostic tool for detecting functional patency of the small bowel: the Given patency capsule. (2005) (132)
Smad7 in TGF-β-mediated negative regulation of gut inflammation (2004) (132)
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer (2011) (131)
Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. (1996) (129)
Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. (2009) (128)
Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease. (2012) (126)
Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer (2011) (124)
Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication. (2006) (123)
Up-Regulation of the IL-12 Receptor β2 Chain in Crohn’s Disease1 (2000) (121)
Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts (2016) (121)
Intestinal inflammation and colorectal cancer: a double-edged sword? (2011) (119)
Multinucleated giant cells generation induced by interferon-gamma. Changes in the expression and distribution of the intercellular adhesion molecule-1 during macrophages fusion and multinucleated giant cell formation. (1994) (118)
Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn's disease (2007) (113)
Characterization of IL-17A–Producing Cells in Celiac Disease Mucosa (2010) (110)
Hepatitis B and C Virus Infection in Crohn's Disease (2001) (108)
Autocrine Regulation of IL-21 Production in Human T Lymphocytes1 (2008) (108)
Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial. (1999) (105)
TGF-β1 and Smad7 in the regulation of IBD (2008) (105)
Combined Oral Sodium Butyrate and Mesalazine Treatment Compared to Oral Mesalazine Alone in Ulcerative Colitis (2000) (104)
Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa (2004) (101)
Severity of postoperative recurrence in crohn's disease: Correlation between endoscopic and sonographic findings (2009) (100)
Appropriate nutrient supplementation in celiac disease (2013) (99)
Enhancing Lamina propria Th1 cell responses with interleukin 12 produces severe tissue injury. (1999) (99)
Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses. (2008) (99)
Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease. (2005) (99)
IL-21 Is Highly Produced in Helicobacter pylori-Infected Gastric Mucosa and Promotes Gelatinases Synthesis1 (2007) (98)
Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer (2011) (97)
New mediators of immunity and inflammation in inflammatory bowel disease (2006) (96)
Interleukin 12 and Th1 responses in inflammatory bowel disease (1998) (96)
Emerging role of IL-23/IL-17 axis in H pylori-associated pathology. (2007) (95)
Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. The Italian IBD Study Group. (1992) (94)
Psoriasis: from pathogenesis to novel therapeutic approaches. (2011) (93)
Development of an index to define overall disease severity in IBD (2016) (92)
Role of TH17 cytokines in the control of colorectal cancer (2013) (90)
Interferon‐gamma‐expressing cells are a major source of interleukin‐21 in inflammatory bowel diseases (2010) (90)
Th17-related cytokines in inflammatory bowel diseases: friends or foes? (2012) (89)
Distinct Profiles of Effector Cytokines Mark the Different Phases of Crohn’s Disease (2013) (87)
123I-interleukin-2 scintigraphy for in vivo assessment of intestinal mononuclear cell infiltration in Crohn's disease. (2000) (87)
The Dual Role of Inflammation in Colon Carcinogenesis (2012) (84)
Continuous in vivo activation and transient hyporesponsiveness to TcR/CD3 triggering of human gut lamina propria lymphocytes (1993) (84)
Clinical trial: ulcerative colitis maintenance treatment with 5‐ASA: a 1‐year, randomized multicentre study comparing MMX® with Asacol® (2009) (84)
Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer (2013) (79)
The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis (2012) (79)
The Dual Role of Smad7 in the Control of Cancer Growth and Metastasis (2013) (78)
Melanosis of the rectum in patients with chronic constipation (1985) (78)
Th17-related cytokines: new players in the control of chronic intestinal inflammation (2011) (77)
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid. (2008) (77)
Seroepidemiology of Helicobacter pylori infection and hepatitis A in a rural area: evidence against a common mode of transmission (1997) (74)
Interleukin-21 as a new therapeutic target for immune-mediated diseases. (2009) (74)
Cytometrically determined relative DNA content as an indicator of neoplasia in gastric lesions. (1984) (72)
Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation. (2006) (71)
Expression of proinflammatory and Th1 but not Th2 cytokines is enhanced in gastric mucosa of Helicobacter pylori infected children. (2001) (71)
Interleukin-23 and Th17 Cells in the Control of Gut Inflammation (2009) (70)
Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection. (2004) (70)
Smad7 in TGF-beta-mediated negative regulation of gut inflammation. (2004) (69)
HLA-DR antigens on colonic epithelial cells in inflammatory bowel disease: I. Relation to the state of activation of lamina propria lymphocytes and to the epithelial expression of other surface markers. (1987) (68)
IL-15 positively regulates IL-21 production in celiac disease mucosa (2012) (68)
Clinical and laboratory indicators of extent of ulcerative colitis. Serum C-reactive protein helps the most. (1988) (67)
Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease. (2009) (67)
Ten and Eight-day Sequential Therapy in Comparison to Standard Triple Therapy for Eradicating Helicobacter pylori Infection: A Randomized Controlled Study on Efficacy and Tolerability (2010) (67)
Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3. (2009) (65)
Up-regulation of the IL-12 receptor beta 2 chain in Crohn's disease. (2000) (65)
Smad7 expression in T cells prevents colitis-associated cancer. (2011) (64)
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut (2014) (64)
Accuracy of small-intestine contrast ultrasonography, compared with computed tomography enteroclysis, in characterizing lesions in patients with Crohn's disease. (2013) (63)
Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa. (1992) (63)
Frequency, Pattern, and Risk Factors of Postoperative Recurrence of Crohn’s Disease After Resection Different from Ileo-Colonic (2009) (63)
Virtual Colonoscopy Compared With Conventional Colonoscopy for Stricturing Postoperative Recurrence in Crohn's Disease (2003) (62)
Mechanisms of tissue damage in inflammatory bowel disease (2001) (61)
A functional role for Smad7 in sustaining colon cancer cell growth and survival (2014) (60)
Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study (2012) (60)
Emerging immunological targets in inflammatory bowel disease. (2011) (60)
Plasma Cells in the Mucosa of Patients with Inflammatory Bowel Disease Produce Granzyme B and Possess Cytotoxic Activities (2014) (59)
A phase 1 open‐label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn's disease (2012) (59)
Extracellular Signal-Regulated Protein Kinase Mediates Interleukin 17 (IL-17)-Induced IL-8 Secretion in Helicobacter pylori-Infected Human Gastric Epithelial Cells (2004) (59)
Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colitis. (1995) (59)
Interleukin-34 sustains inflammatory pathways in the gut. (2015) (59)
Development of a numerical index quantitating small bowel damage as detected by ultrasonography in Crohn's disease. (2012) (58)
Interferon Expression in Crohn's Disease Patients: Increased Interferon-γ and -α mRNA in the Intestinal Lamina Propria Mononuclear Cells (1994) (58)
Resident bacterial flora and immune system. (2002) (57)
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study. (2007) (56)
Lactobacillus paracasei subsp. paracasei B21060 Suppresses Human T-Cell Proliferation (2007) (56)
Interleukin-12 Drives the Th1 Signaling Pathway in Helicobacter pylori-Infected Human Gastric Mucosa (2007) (54)
Effects of somatostatin on human intestinal lamina propria lymphocytes. Modulation of lymphocyte activation (1991) (54)
Helicobacter pylori infection in children with celiac disease: prevalence and clinicopathologic features. (1999) (54)
Salivary-specific immunoglobulin G in the diagnosis of Helicobacter pylori infection in dyspeptic patients. (1995) (53)
TNF-α Producing Innate Lymphoid Cells (ILCs) Are Increased in Active Celiac Disease and Contribute to Promote Intestinal Atrophy in Mice (2015) (52)
Treatment with biologic therapies and the risk of cancer in patients with IBD (2007) (52)
Oral 5-Aminosalicylic Acid (Asacol) in the Maintenance Treatment of Crohnʼs Disease (1993) (51)
Aryl hydrocarbon receptor and colitis (2013) (50)
Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7 (1998) (50)
Use of anti-tumour necrosis factor agents in inflammatory bowel disease (2001) (50)
A sonographic lesion index for Crohn's disease helps monitor changes in transmural bowel damage during therapy. (2014) (50)
TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease. (2013) (50)
Cancer and Immunomodulators in Inflammatory Bowel Diseases (2015) (49)
Cancer in Crohn's Disease patients treated with infliximab: A long‐term multicenter matched pair study (2011) (49)
Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population. (2002) (48)
IL‐25 prevents and cures fulminant hepatitis in mice through a myeloid‐derived suppressor cell‐dependent mechanism (2013) (48)
Transglutaminases in Crohn's disease. (1995) (47)
Frataxin participates to the hypoxia-induced response in tumors (2011) (47)
Constitutive activation of the signal transducer and activator of transcription pathway in celiac disease lesions. (2003) (47)
Modulation of human natural killer activity by vasoactive intestinal peptide (VIP) family. VIP, glucagon and GHRF specifically inhibit NK activity (1992) (46)
99mTc-interleukin-2 and 99mTc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease (2003) (46)
Wireless capsule endoscopy and proximal small bowel lesions in Crohn's disease. (2010) (46)
Antral nodularity identifies children infected with Helicobacter pylori with higher grades of gastric inflammation. (2001) (46)
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population. (2004) (46)
Inhibition of colitis by IL‐25 associates with induction of alternatively activated macrophages (2012) (45)
Salivary immunoglobulin G assay to diagnose Helicobacter pylori infection in children (1997) (45)
Interleukin-25: a two-edged sword in the control of immune-inflammatory responses. (2010) (45)
Endoscopic vs ultrasonographic findings related to Crohn's disease recurrence: a prospective longitudinal study at 3 years. (2010) (45)
Th17 immune response in IBD: A new pathogenic mechanism. (2008) (44)
Rofecoxib and early relapse of inflammatory bowel disease: an open‐label trial (2004) (43)
Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies. (2009) (43)
Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis (2015) (43)
Interleukin-34 Induces Cc-chemokine Ligand 20 in Gut Epithelial Cells. (2016) (43)
Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells (2006) (42)
Technetium-99m–HMPAO Labeled Leukocyte Single Photon Emission Computerized Tomography (SPECT) for Assessing Crohn's Disease Extent and Intestinal Infiltration (2005) (42)
Appendectomy is an independent protective factor for ulcerative colitis: results of a multicentre case control study. The Italian Group for the Study of the Colon and Rectum (GISC) (1997) (42)
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN-γ–Dependent Epidermal Hyperplasia (2011) (41)
Th17 Cytokines in Inflammatory Bowel Diseases: Discerning the Good from the Bad (2013) (41)
Vasoactive intestinal polypeptide modulates the in vitro immunoglobulin A production by intestinal lamina propria lymphocytes. (1994) (41)
Interleukin-25 production is differently regulated by TNF-α and TGF-β1 in the human gut (2011) (40)
CARD15 Mutation Analysis in an Italian Population: Leu1007fsinsC but Neither Arg702Trp nor Gly908Arg Mutations Are Associated with Crohn’s Disease (2004) (40)
Aryl hydrocarbon receptor‐driven signals inhibit collagen synthesis in the gut (2016) (40)
Immunomodulatory drugs in Crohn's disease patients with hepatitis B or C virus infection. (2002) (39)
Impact of patient characteristics on the clinical efficacy of mongersen (GED‐0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease (2016) (39)
Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells. (2014) (37)
Non-invasive techniques for assessing postoperative recurrence in Crohn's disease. (2008) (37)
The biological relevance of polykaryons in the immune response. (1997) (37)
Unsedated transnasal versus transoral sedated upper gastrointestinal endoscopy: a one-series prospective study on safety and patient acceptability. (2008) (37)
Molecular basis of the potential of mesalazine to prevent colorectal cancer. (2008) (37)
Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer (2012) (37)
Interleukin-21 triggers effector cell responses in the gut. (2010) (37)
TGF-Beta signaling manipulation as potential therapy for IBD. (2013) (36)
Antral Nodularity and Positive CagA Serology are Distinct and Relevant Markers of Severe Gastric Inflammation in Children with Helicobacter pylori Infection (2002) (36)
Post-operative recurrence of Crohn's disease: A prospective study at 5 years. (2016) (36)
99mTc-HMPAO Granulocyte Scintigraphy in the Early Detection of Postoperative Asymptomatic Recurrence in Crohn's Disease (1997) (35)
Anti-TNF-alpha treatments and obstructive symptoms in Crohn's disease: a prospective study. (2013) (35)
Local injection of infliximab in the postoperative recurrence of Crohn's disease (2006) (35)
Digestive and Liver Disease (2011) (35)
Tropomyosin expression in the ileal pouch: a relationship with the development of pouchitis in ulcerative colitis (2003) (35)
Targets for new immunomodulation strategies in inflammatory bowel disease. (2014) (34)
Targeting IL-23 and Th17-cytokines in inflammatory bowel diseases. (2010) (34)
Tissue inhibitor of metalloproteinase-3 regulates inflammation in human and mouse intestine. (2012) (34)
Interferon expression in Crohn's disease patients: increased interferon-gamma and -alpha mRNA in the intestinal lamina propria mononuclear cells. (1994) (34)
Lesional Accumulation of CD163-Expressing Cells in the Gut of Patients with Inflammatory Bowel Disease (2013) (34)
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients. (2016) (33)
Maintenance treatment of Crohn's disease (2003) (33)
Analysis of the cytokine profile in the duodenal mucosa of refractory coeliac disease patients. (2014) (33)
Fecal α1-antitrypsin clearance as a marker of clinical relapse in patients with Crohn's disease of the distal ileum (2003) (32)
Autophagy and inflammatory bowel disease: Association between variants of the autophagy-related IRGM gene and susceptibility to Crohn's disease. (2015) (32)
Helicobacter pylori-specific IgG in chronic haemodialysis patients: relationship of hypergastrinaemia to positive serology. (1996) (32)
Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study. (2016) (31)
Colorectal Cancer Chemoprevention by Mesalazine and Its Derivatives (2012) (31)
Analysis of clinical course of postoperative recurrence in Crohn's Disease of distal ileum (1992) (31)
A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis. (2006) (30)
Frequency and Cause of Persistent Symptoms in Celiac Disease Patients on a Long-term Gluten-free Diet (2016) (30)
Involvement of interleukin-15 and interleukin-21, two γ-chain-related cytokines, in celiac disease (2009) (30)
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study. (2015) (30)
Ability of human colonic epithelium to express the 4F2 antigen, the common acute lymphoblastic leukemia antigen, and the transferrin receptor. Studies in inflammatory bowel disease and after in vitro exposure to different stimuli. (1989) (30)
Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis. (1998) (30)
Effect of Rifaximin on Intestinal Bacterial Overgrowth in Crohn's Disease as Assessed by the H2-Glucose Breath Test (2000) (30)
IOIBD questionnaire on the clinical use of azathioprine, 6‐mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases (2000) (30)
Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study. (2012) (29)
Interleukin-23R Arg381Gln is associated with susceptibility to Crohn's disease but not with phenotype in an Italian population. (2007) (29)
HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli. (1988) (28)
Inability of normal human intestinal macrophages to form multinucleated giant cells in response to cytokines. (1995) (28)
Antisense Approach to Inflammatory Bowel Disease: Prospects and Challenges (2015) (28)
Role of Smad7 in inflammatory bowel diseases. (2012) (28)
Real-time Interobserver Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn's Disease: An International Multicenter Study. (2018) (28)
Evidence against an increased risk of Helicobacter pylori infection in dentists: a serological and salivary study. (1995) (27)
Small bowel capsule endoscopy vs conventional techniques in patients with symptoms highly compatible with Crohn's disease. (2011) (27)
Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patients. (2009) (27)
Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase. (2008) (26)
Testing for serum IgG antibodies to Helicobacter pylori cytotoxin-associated protein detects children with higher grades of gastric inflammation. (1999) (26)
Targeting interleukin-21 in inflammatory diseases (2011) (26)
Salivary specific IgG is a sensitive indicator of the humoral immune response to Helicobacter pylori. (1995) (26)
A simplified, non-invasive fecal-based DNA integrity assay and iFOBT for colorectal cancer detection (2011) (26)
Postheparin plasma diamine oxidase in patients with small bowel Crohn's disease. (1988) (25)
Small intestine contrast ultrasonography vs computed tomography enteroclysis for assessing ileal Crohn's disease. (2012) (25)
ATG16L1 Ala197Thr is not associated with susceptibility to Crohn's disease or with phenotype in an Italian population. (2008) (25)
Enhanced Expression of Interferon Regulatory Factor-1 in the Mucosa of Children with Celiac Disease (2003) (25)
Effects of sucralfate and sulglycotide treatment on active gastritis and Helicobacter pylori colonization of the gastric mucosa in non-ulcer dyspepsia patients. (1990) (24)
5-aminosalicylic acid enhances anchorage-independent colorectal cancer cell death. (2006) (24)
Ultrasound of the Small Bowel in Crohn's Disease (2012) (24)
Interleukin‐21 in chronic inflammatory diseases (2013) (23)
Genetic and pathogenetic insights into inflammatory bowel disease (2003) (23)
IL-21 as a therapeutic target in inflammatory disorders (2014) (23)
Isotypic analysis of antibody response to a food antigen in inflammatory bowel disease. (1985) (23)
In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique. (1981) (23)
CCL20 Is Negatively Regulated by TGF-&bgr;1 in Intestinal Epithelial Cells and Reduced in Crohn’s Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide (2016) (23)
Isotypic analysis of specific antibody response in serum, saliva, gastric and rectal homogenates of Helicobacter pylori-infected patients. (1995) (23)
Studies of peripheral blood lymphocytes in Crohn's disease. Circulating activated T cells. (1983) (22)
High Expression of the “A Disintegrin And Metalloprotease” 19 (ADAM19), a Sheddase for TNF-&agr; in the Mucosa of Patients with Inflammatory Bowel Diseases (2013) (22)
Interleukin-21 (IL-21) controls inflammatory pathways in the gut. (2007) (22)
An Overview of the Role of Innate Lymphoid Cells in Gut Infections and Inflammation (2014) (21)
Serum regenerating islet‐derived 3‐alpha is a biomarker of mucosal enteropathies (2014) (21)
Impairment of ghrelin synthesis in Helicobacter pylori-colonized stomach: new clues for the pathogenesis of H. pylori-related gastric inflammation. (2014) (21)
Bacteria and mucosal immunity. (2006) (21)
Gastrin, antral g cells, and gastric acid in secretagogue-induced and antihistamine-inhibited duodenal ulcers. (1977) (21)
Abnormal patterns of colonic mucin secretion after ureterosigmoidostomy. (1984) (20)
Proteinase activated-receptors-associated signaling in the control of gastric cancer. (2014) (20)
Selective cyclooxygenase-2 inhibitors and relapse of inflammatory bowel disease. (2003) (20)
Local injection of infliximab in the postoperative recurrence of Crohn's disease. (2006) (20)
The IL-12/23/STAT Axis as a Therapeutic Target in Inflammatory Bowel Disease: Mechanisms and Evidence in Man (2015) (20)
Role of interleukin-21 in inflammation and allergy. (2007) (20)
Interleukin-21 in cancer immunotherapy (2012) (20)
Post-endoscopic retrograde cholangio-pancreatography pancreatitis: is time for a new preventive approach? (2012) (20)
2-Methoxy-5-Amino-N-Hydroxybenzamide Sensitizes Colon Cancer Cells to TRAIL-Induced Apoptosis by Regulating Death Receptor 5 and Survivin Expression (2011) (20)
Usefulness of fecal α1-antitrypsin clearance and fecal concentration as early indicator of postoperative asymptomatic recurrence in crohn's disease (1991) (18)
High seroprevalence of Helicobacter pylori infection in non-institutionalised children with mental retardation. (2004) (18)
Nutritional status and bioelectrical phase angle assessment in adult Crohn disease patients receiving anti-TNFα therapy. (2017) (18)
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine. (2010) (18)
Evaluation of the Given Patency System in the GI Tract: Results of a Multi-Center Study (2004) (18)
Sampling of proximal and distal duodenal biopsies in the diagnosis and monitoring of celiac disease. (2014) (17)
Role of IL-21 in inflammatory bowel disease (2010) (17)
What is the role of cytokines and chemokines in IBD? (2008) (17)
Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFα reduce colitis-associated colorectal carcinogenesis? (2009) (17)
Suggestion Against an Oral-Oral Route of Transmission for Helicobacter pylori Infection (A Seroepidemiological Study in a Rural Area) (1998) (17)
Metastatic Crohn's Disease of the Forehead (2002) (17)
Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease. (2009) (17)
Review article: monitoring the activity of Crohn's disease. (2002) (17)
Regulatory cytokines in inflammatory bowel disease. (1996) (16)
Low efficacy of levofloxacin-doxycycline-based third-line triple therapy for Helicobacter pylori eradication in Italy. (2015) (16)
Raised serum levels of IgM-rheumatoid factor and anti-F(ab')2 autoantibodies in patients with active inflammatory bowel disease. (1986) (16)
Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells (2016) (15)
Smad7 antisense oligonucleotide-based therapy for inflammatory bowel diseases. (2013) (15)
Look out before polypectomy in patients with diverticular disease--a case of a large, inverted diverticulum of the colon resembling a pedunculated polyp. (2010) (15)
Adenoma, advanced adenoma and colorectal cancer prevalence in asymptomatic 40‐ to 49‐year‐old subjects with a first‐degree family history of colorectal cancer (2013) (15)
Earthquake-induced landslide scenarios for seismic microzonation: application to the Accumoli area (Rieti, Italy) (2019) (15)
Effects of high in vivo levels of vasoactive intestinal polypeptide on function of circulating lymphocytes in humans. (1990) (15)
CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide. (2016) (15)
Ultrasound in Crohn's disease. (2012) (14)
Interleukin-21 in immune and allergic diseases. (2012) (14)
Current treatment modalities in active Crohn's disease. (1999) (14)
Targeting interleukin-21 in immune-mediated pathologies. (2010) (14)
Familial colorectal cancer screening: When and what to do? (2015) (13)
Monitoring the activity of Crohn's disease (2002) (13)
High Smad7 sustains inflammatory cytokine response in refractory coeliac disease (2017) (13)
Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation (2008) (12)
Campylobacter-like organisms on the human gastric mucosa. Relation to type and extent of gastritis in different clinical groups. (1987) (12)
Interleukin‐25 fails to activate STAT6 and induce alternatively activated macrophages (2011) (12)
Smoking, alcohol and coffee consumption, and H pylori infection (1998) (12)
Interferon-alpha (IFN-alpha) production by human intestinal mononuclear cells. Response to virus in control subjects and in Crohn's disease. (1992) (12)
Interleukin-21 in T cell-mediated diseases. (2009) (11)
"In vitro" azathioprine-induced changes in peripheral T cell apoptosis and IFN-γ production associate with drug response in patients with Crohn's Disease. (2013) (11)
Usefulness of fecal alpha 1-antitrypsin clearance and fecal concentration as early indicator of postoperative asymptomatic recurrence in Crohn's disease. (1991) (11)
Disruption of inflammatory signals by cytokine‐targeted therapies for inflammatory bowel diseases (2012) (11)
Serum angiotensin converting enzyme activity in Crohn's disease and ulcerative colitis. (1993) (11)
The dual role of interleukin-25 in the control of immune-mediated pathologies. (2011) (11)
Cytokine therapies in Crohn's disease: where are we now and where should we go? (2011) (11)
Abnormal patterns of colorectal mucin secretion after urinary diversion of different types: histochemical and lectin binding studies. (1986) (11)
Circulating D dimer in inflammatory bowel disease. (1994) (10)
Measuring disease activity in Crohn’s disease (2012) (10)
T cell early activation antigens expressed by peripheral lymphocytes in Crohn's disease. (1985) (10)
Human cervical epithelial cells that express HLA-DR associated with viral infection and activated mononuclear cell infiltrate. (1991) (10)
Altered IgG(4) renal clearance in patients with inflammatory bowel diseases. Evidence for a subclinical impairment of protein charge renal selectivity. (2000) (10)
Absence of circulating interferon in patients with inflammatory bowel disease. Suggestion against an autoimmune etiology (1992) (10)
WITHDRAWN: A Functional Role for Interleukin-21 in Promoting the Synthesis of the T Cell Chemoattractant, MIP-3α, by Gut Epithelial Cells (2006) (10)
Phenotypes and spontaneous immunoglobulin production in mononuclear cells suspensions isolated from colonic biopsies of patients with mild active and quiescent ulcerative colitis. (1991) (9)
Th17-cytokine blockers as a new approach for treating inflammatory bowel disease (2011) (9)
Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial (2018) (9)
A methodology for a comprehensive assessment of earthquake-induced landslide hazard, with an application to pilot sites in Central Italy (2016) (9)
Ultrasonographic assessment of gallbladder bile exchanges in healthy subjects and in gallstone patients. (2001) (9)
Frequency and extent of bulbar duodenitis in duodenal ulcer, endoscopic and histological study. (1982) (9)
Ileal lesions in patients with ulcerative colitis after ileo-rectal anastomosis: relationship with colonic metaplasia. (2008) (9)
Helicobacter pylori Infection Associates with a Mucosal Downregulation of Ghrelin, Negative Regulator of Th1‐Cell Responses (2013) (8)
Evidence against colonic mucosa colonisation by Helicobacter pylori. Lack of a specific antibody response in homogenates of rectal endoscopic biopsies. (1996) (8)
Small bowel Epstein–Barr virus‐positive lympho‐epithelioma‐like carcinoma in Crohn's disease (2017) (7)
Pyoderma gangrenosum in refractory celiac disease: a case report (2013) (7)
Targeting Integrins and Adhesion Molecules to Combat Inflammatory Bowel Disease (2014) (7)
Changes in the mucosal expression of interleukin 15 in Helicobacter pylori-associated gastritis. (1999) (7)
Evaluation of a commercial serological kit for detection of salivary immunoglobulin G toHelicobacter pylori (1997) (6)
Defective Expression of Scavenger Receptors in Celiac Disease Mucosa (2011) (6)
Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease. (2015) (6)
826 Impact of Severity and Duration of Active Crohn's Disease on the Clinical Efficacy of Mongersen (GED-0301), an Oral Smad7 Antisense Oligonucleotide (2015) (6)
Humoral Inhibition of Neutrophil Chemotaxis in Crohn's Disease (1985) (6)
Antineutrophil cytoplasmic antibodies are present in long standing type 1 diabetics but do not correlate with selective proteinuria. (1996) (6)
Interleukin-25 negatively controls pathogenic responses in the gut. (2011) (6)
Antibacterial drugs in Crohn's disease. (1992) (6)
Rectal laterally spreading tumors successfully treated in two steps by endoscopic submucosal dissection and endoscopic mucosal resection (2010) (6)
Lansoprazole and Helicobacter pylori infection. (1993) (6)
Large villous adenoma of the appendix: a case treated with sequential endoscopic-minimal surgical technique. (2009) (6)
Frequency and pattern of endoscopic recurrence in Crohn's disease patients with ileocolonic resection using a laparoscopic versus laparotomic approach: a prospective longitudinal study. (2008) (6)
New evidence of circulating immune complexes in Crohn's disease using two sensitive methods. (1981) (6)
Quantitative denaturing high performance liquid chromatography (Q-dHPLC) detection of APC long DNA in faeces from patients with colorectal cancer (2010) (6)
The function in vitro of macrophages from the intestinal mucosa of patients with Crohn's disease: An association between chemotactic migration and granulomata (1988) (6)
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation. (2009) (6)
Lymphocyte activation by B. subtilis spores. (1987) (5)
Peripheral and intestinal lymphocyte activation after in vitro exposure to cow's milk antigens in normal subjects and in patients with Crohn's disease. (1987) (5)
T cell differentiation antigens expressed by peripheral blood lymphocytes in Crohn's disease. (1985) (5)
Fine mapping of the inflammatory bowel disease susceptibility locus 1 (IBD1) in the pericentromeric region of chromosome 16 (1998) (5)
Interleukin (IL)-17 is ffighly produced in Helicobacter pylori-infected human gastric mucosa and upregulates bioactive IL-8 expression (2000) (5)
IL-4 hyporesponsiveness of Crohn's disease mucosal T lymphocytes: a response of polarised Th1 cells? (2000) (5)
Impact of endoscopic ultrasound-guided fine-needle aspiration and multidisciplinary approach in the management of abdominal or mediastinal mass (2015) (5)
Date of birth in familial Crohn's disease suggests environmental factors (1998) (5)
UEG Week 2016 Poster Presentations (2016) (4)
Targeting T cells in Chronic Inflammatory Bowel Diseases (2013) (4)
Colonic Phenotype of the Ileum in Crohn's Disease: A Prospective Study Before and After Ileocolonic Resection (2014) (4)
390 Maintenance Treatment of Ulcerative Colitis with 5-Aminosalicylic Acid (5-ASA): Results from the Italian Population of a One Year, Randomized, Multinational Study Comparing MMx® with Asacol® (2009) (4)
Gut neuropeptides and the immune system (1991) (4)
A family study of asymptomatic small bowel Crohn's disease. (2014) (4)
Positioning Ultrasonography Into Clinical Practice for the Management of Crohn's Disease. (2015) (4)
Further evidence for a genetic association of interleukin-1 receptor antagonist with ulcerative colitis in a northern and a mediterranean population (1995) (4)
M1065 Sequential Regimens Have Greater Efficacy and Better Tolerability Than Standard Triple Therapy in the Eradication of Helicobacter pylori Infection (2008) (4)
MHC class II antigens on the epithelial cells of the human gastrointestinal tract. (1992) (4)
T1136 Once-Daily MMX® 5-Aminosalicylic Acid Versus Twice-Daily Asacol® for the Maintenance of Remission of Ulcerative Colitis: A Preliminary Analysis (2008) (4)
Spontaneous release of interferon y by intestinal lamina propria lymphocytes in Crohn ' s disease . Kinetics of in vitro response to interferon y inducers (2006) (3)
CONSERVATIVE MANAGEMENT OF ACUTE INTESTINAL OBSTRUCTION IN CROHN'S DISEASE (1984) (3)
PA.159 COMPARISON BETWEEN TECHNIQUES PROVIDING VIEW OF THE LUMINAL VS EXTRALUMINAL SURFACE IN ASSESSING CROHN'S DISEASE RECURRENCE: A PROSPECTIVE LONGITUDINAL STUDY (2008) (3)
Extracellular Signal-Regulated Protein Kinase Mediates Interleukin 17 (IL-17)-Induced IL-8 Secretion in Helicobacter pylori-Infected Human Gastric Epithelial Cells (2014) (3)
Smad7 Sustains Inflammation in the Gut: From Bench to Bedside (2014) (3)
Usefulness of salivary Helicobacter pylori antibodies (1995) (3)
Mucosal and systemic antibody levels against Helicobacter pylori do not parallel gastric inflammatory changes. (1998) (2)
Helicobacter pylori Transmission and Hepatitis A (1998) (2)
Crypt epithelial cells express the 4F2 antigen in untreated coeliac mucosa. (1995) (2)
Correction to: Earthquake-induced landslide scenarios for seismic microzonation: application to the Accumoli area (Rieti, Italy) (2019) (2)
P.05.7 ILEOCOLONOSCOPY AND SMALL INTESTINE CONTRAST ULTRASONOGRAPHY (SICUS) AS PREDICTORS OF CLINICAL OUTCOME AFTER ILEO-COLONIC RESECTION FOR CROHN'S DISEASE: A PROSPECTIVE STUDY AT 5 YEARS (2012) (2)
A limiting-dilution analysis of activated circulating B cells in Crohn's disease (1990) (2)
ARYL HYDROCARBON RECEPTOR SIGNALLING DOWN REGULATES TH1 IMMUNO-RESPONSE IN CROHN'S DISEASE GUT MUCOSA (2009) (2)
Outcome of ulcer-associated duodenitis after short-term medical treatment (1985) (2)
Investigational cytokine-targeted therapies for ulcerative colitis (2013) (2)
Cytoskeletal proteins and resident flora. (2002) (2)
Updates on diagnosis: new tools? How can we measure activity? (2008) (2)
Su1199 Small Bowel Capsule Endoscopy for Assessing Early Postoperative Recurrence of Crohn's Disease: A Prospective Longitudinal Study (2013) (2)
Helisal saliva assay (1997) (2)
PEG-IFN for hepatitis C in clinical practice (2009) (2)
ApplICAtIon of the pArsIfAl ApproACh for proVIdInG sCenArIos of eArthquAke-InduCed lAndslIde In the ACCumolI munICIpAlIty (2018) (2)
Deletion of REXO1L1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: a novel recognizable microdeletion syndrome? (2015) (2)
DOP093 Characterisation of incident cases of cancer in inflammatory bowel disease: A prospective multicenter matched-pair IG-IBD study (2014) (2)
Fecal α1-antitrypsin as early indicator of clinical relapse in Crohn's disease: Results from a 4-year follow-up (1998) (2)
Paternal and maternal infection status and Helicobacter pylori in their children. (1999) (2)
241 Interleukin (IL)-25 Inhibits IL-12 Production and TH1 Cell-Driven Inflammation in the Gut (2009) (2)
RIFAXIMIN IN INACTIVE CROHN'S DISEASE : EFFECT ON THE INTESTINAL PROTEIN LOSS AS ASSESSED BY THE FECAL ALPHA L-ANTITRYPSIN CLEARANCE (1998) (2)
Tu1962 Looking Beyond Symptoms and Disease Activity to Define Disease Severity in Inflammatory Bowel Disease: Results of an IOIBD Specialist Panel (2016) (2)
Local immune activity in acute coronary syndrome: oxLDL abrogates LPS-tolerance in mononuclear cells isolated from culprit lesion. (2013) (2)
P.18.8 IL-25 PREVENTS AND CURES FULMINANT HEPATITIS THROUGH A MYELOID-DERIVED SUPPRESSOR CELL-DEPENDENT MECHANISM (2013) (2)
SMAD7 EXPRESSION IN T CELLS PROTECTS FROM COLITIS-ASSOCIATED COLORECTAL CANCER (2009) (1)
HELICOBACTER PYLORI-INFECTED HUMAN GASTRIC MUCOSA (2007) (1)
SMALL INTESTINE CONTRAST ULTRASONOGRAPHY FOR DETECTING ASYMPTOMATIC SMALL BOWEL CROHN'S DISEASE LESIONS: A FAMILY STUDY (2009) (1)
Severity of Crohn’s disease recurrence after ileo-colon resection: correlation between endoscopic score and sonographic findings. (2007) (1)
I.O.I.B.D. Questionnaire on the clinical use of Azathioprine, 6-Mercaptopurine, Cyclosporine-A and Methotrexate in the treatment of I.B.D (1996) (1)
Interleukin-12 receptor β2, a crucial component in the IL-12 TH1 response, is up-regulated in Crohn's disease (2000) (1)
Regulation of matrix metalloproteinases (MMPs) synthesis by interleukin-21 (IL-21) in human intestinal fibroblasts (2006) (1)
[Double-blind clinical experiences with a new anti-rheumatic drug: ibuprofen. Gastroscopic and gastrobioptic study of cases of drug intolerance]. (1973) (1)
Sa1262 Patient-Reported Outcomes With GED-0301 (Mongersen), an Oral Smad7 Antisense Oligonucleotide, in Active Crohn's Disease: Correlation of PRO2 With CDAI Score (2015) (1)
Su1120 Impact of Small Intestine Contrast Ultrasonography in the Management of Crohn's Disease Patients (2013) (1)
1155 PEG-IFN FOR CHRONIC HEPATITIS C IN CLINICAL PRACTICE: THE PROSPECTIVE PHASE OF THE AIFA STUDY (2012) (1)
Small intestine contrast ultrasonography (SICUS) versus videocapsule endoscopy (VCE) for assessing Crohn's disease post-operative recurrence: A prospective longitudinal study (2006) (1)
P.06.5 A FUNCTIONAL ROLE FOR IL-34 IN SUSTAINING INFLAMMATORY PATHWAYS IN IBD (2014) (1)
Centenarians and Helicobacter pylori. (2000) (1)
Comparative Randomized Study Between TN-PEG Versus O-PEG in Unselected Population (2008) (1)
Targeted inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-β1-mediated suppression of mucosal inflammation (2006) (1)
P073 - Luminal vs extraluminal findings compatible with Crohn's disease recurrence: prospective longitudinal study 3 years after surgery (2009) (1)
Histological analysis and cytoskeletal proteins expression on ileal mucosa before and after ileal pouch for ulcerative colitis (2001) (1)
P.84 OUTCOME OF PATIENTS WITH MODERATE-SEVERE ULCERATIVE COLITIS: A LONGITUDINAL STUDY IN PATIENTS UNDER REGULAR FOLLOW-UP (2010) (1)
P109 Thiopurines and anti-TNFs after a diagnosis of cancer in patients with inflammatory bowel disease (2014) (1)
P.01.4 CONTRAST ENHANCED ULTRASOUND AS A VALUABLE TOOL IN COMPLICATED CROHN'S DISEASE PATIENTS (2013) (1)
GIVEN® PATENCY SYSTEM IS A NEW DIAGNOSTIC TOOL FOR VERIFYING FUCTIONAL PATENCY OF THE SMALL BOWEL: 188 (2004) (1)
Helisal saliva assay. (1997) (1)
Local Injection of Infliximab in the Postoperative Recurrence of Crohn's Disease During Endoscopy: A Prospective Longitudinal Study (2006) (1)
P150 Small bowel capsule endoscopy for assessing early postoperative recurrence of Crohn's disease: a prospective longitudinal study (2013) (1)
Mo1175 Thiopurines and Anti-TNFs in Patients With Inflammatory Bowel Disease and a Previous Diagnosis of Cancer (2014) (1)
Using the Video Endoscope Prototype Olympus XGIF-N160Y1 for Transnasal Gastroscopy: A Pilot Study of Feasibility and Tolerability (2005) (1)
P.11.8: Inter-Observer Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients with Crohn’s Disease (2017) (1)
Su1117 Contrast Enhanced Ultrasound As a Valuable Tool in Complicated Crohn's Disease Patients (2013) (1)
Phenotypic concordance and time clustering of diagnosis in multiply affected ibd families : the IOIBD Multiplex Family Collaborative Project, phases I a II (2005) (1)
Interleukin (IL)-17 is highly produced in Helicobacter pylori-infected human gastric mucosa and upregulates bioactive IL-8 expression (2000) (1)
Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study. (2001) (1)
P.06.9 SMALL BOWEL CAPSULE ENDOSCOPY IN CROHN'S DISEASE VS CONTROLS: DETECTION OF UPPER GASTROINTESTINAL LESIONS, IMPACT RATE, GASTRIC AND SMALL BOWEL TRANSIT TIMES IN A TERTIARY REFERRAL CENTER (2012) (1)
S1682 Aryl Hydrocarbon Receptor Signalling Down Regulates TH1 Immuno-Response in Crohn's Disease Gut Mucosa (2009) (1)
Lactobacillus GG is not effective in subsiding bowel tenderness in inactive Crohn's disease (2003) (1)
Wireless capsule endoscopy in Crohn’s disease: clinical relevance of upper GI lesions and feasibility 2 years after ileo-colonic resection. (2007) (1)
P.77 BIOLOGIC THERAPIES, THIOPURINES AND CANCER IN INFLAMMATORY BOWEL DISEASE: A SINGLE-CENTER COHORT STUDY IN 1118 PATIENTS (2010) (1)
IL-21, a new player in pathogenesis of psoriasis (2009) (1)
Ultrasound in Crohns Disease (2012) (1)
OC1.08.6 NEWLY DIAGNOSED CANCER IN A COHORT OF CROHN'S DISEASE PATIENTS TREATED WITH INFLIXIMAB: A 3 YEARS LONGER FOLLOW UP FROM A MULTICENTER MATCHED-PAIR STUDY (2008) (1)
Sa1265 Ileocolonoscopy and Small Intestine Contrast Ultrasonography (SICUS) as Predictors of Clinical Outcome After Ileo-Colonic Resection for Crohn's Disease: A Prospective Study at 5 Years (2012) (1)
Book Review / Books Received at the Editorial Office (1985) (1)
Newly diagnosed neoplasia in a cohort of Crohn’s Disease patients treated with Infliximab: a 3 years longer follow up from a multicenter matched-pair study. (2008) (1)
Centenarians and Helicobacter pylori (2000) (1)
Tu1676 Distinct Profiles of Effector Cytokines Mark the Different Phases of Crohn's Disease (2013) (1)
The prevalence of Helicobacter pylori infection is not increased in children with celiac disease (1998) (1)
P.05.11 HIGH EXPRESSION OF THE “A DISINTEGRIN AND METALLOPROTEASE” 19 (ADAM19), A SHEDDASE FOR TNF-α IN THE MUCOSA OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES (2012) (1)
Induction of T-bet and silencing of GATA-3 underlie Th1 polarisation in helicobacter pylori-infected human gastric mucosa (2001) (1)
Transnasal Versus Oral PEG Placement in Unselected Patients: A Prospective Randomized Clinical Trial (2009) (1)
P.1.189: SMALL INTESTINE CONTRAST ULTRASONOGRAPHY FOR DETECTING ASYMPTOMATIC SMALL BOWEL CROHN'S DISEASE LESIONS: A FAMILY STUDY (2011) (1)
OC.11.4 FOOD PRESERVATIVES AND ADDITIVES EXACERBATE INTESTINAL INFLAMMATION (2016) (1)
Interferons production by cultured lamina propria mononuclear cells in Crohn’s disease and controls (1990) (1)
P.03.8 PEG-IFN FOR CHRONIC HEPATITIS C IN CLINICAL PRACTICE: THE PROSPECTIVE PHASE OF THE AIFA STUDY (2012) (1)
M1134 Newly Diagnosed Neoplasia in a Cohort of Crohn's Disease Patients Treated with Infliximab: A 3 Years Longer Follow Up from a Multicenter Matched-Pair Study (2008) (1)
Enhanced expression of the Fas pathway inhibitor, Flip, in the mucosa of patients with Crohn's disease (2004) (1)
Gliadin induces HLA-DR expression on crypt epithelium during organ culture of treated coeliac mucosa (1990) (1)
2-14, A NOVEL DERIVATIVE OF 5-AMINOSALICYLIC ACID, INDUCES ENDOPLASMATIC RETICULUM (ER) STRESS AND PREVENTS COLITIS-ASSOCIATED COLON CANCER (CC) (2009) (1)
P267 - Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression (2009) (1)
493 Bowel Damage After Biological Therapy Assessed by Sonographic Lesion Index for Crohn's Disease (2013) (1)
OC3.02.6 SEQUENTIAL REGIMENS HAVE GREATER EFFICACY AND BETTER TOLERABILITY THAN STANDARD TRIPLE THERAPY IN THE ERADICATION OF HELICOBACTER PYLORI INFECTION (2008) (1)
P.08.1 IMPACT OF SMALL INTESTINE CONTRAST ULTRASONOGRAPHY IN THE MANAGEMENT OF CROHN'S DISEASE PATIENTS (2013) (1)
91 Small Intestine Contrast Ultrasonography (SICUS) and CT-Enteroclysis in the Assessment of Crohn's Disease Lesions (2012) (1)
Scintigraphy using 99m-technetium-HMPAO labelled granulocytes and 123I-labelled interleukin-2 in Crohn's disease: A comparative study (2000) (0)
P.05.19 ASYMPTOMATIC SMALL BOWEL CROHN'S DISEASE: A FAMILY STUDY (2012) (0)
14 P Spontaneous remission of Crohn's disease during pregnancy relation with placental immunomodulatory factors (2002) (0)
P.03.8 CLINICAL IMPACT OF EUS–FNA ON DIAGNOSTIC WORK UP AND THERAPEUTIC DECISION IN PATIENTS WITH SUSPICION OF MALIGNANT LESIONS (2014) (0)
OC.03.2 DEFECTIVE EXPRESSION OF THE ANTI-INFLAMMATORY SIRT1 IN INFLAMMATORY BOWEL DISEASES (2012) (0)
M2021 Increased Expression of Interleukin 17 in Celiac Disease Mucosa (2009) (0)
Interleukin (IL)-12 receptor β2 subunit expression is up-regulated in helicobacter pylori infected gastric mucosa (2000) (0)
Uncovered metal stents for management of inoperable malignant colorectal strictures (2006) (0)
P106 5-Aminosalycilic Acid (5-ASA)-Mediated Block of Colon Cancer Cell Growth is Associated With Degradation Of CDC25A and Accumulation of Cells in S-Phase (2007) (0)
Sa1998 Innate Lymphoid Cells Are Increased in Celiac Disease Intestinal Mucosa and Have a Pathogenic Role in a Mouse Model of Small Intestine Atrophy (2014) (0)
P019 - Diagnostic role of wireless capsule endoscopy in patients with symptoms highly compatible with Crohn's disease (2009) (0)
P400 Psoriasis phenotype in inflammatory bowel disease (2013) (0)
CHARACTERIZATION OF IL-21 PRODUCING CELLS IN INFLAMMATORY BOWEL DISEASE (2009) (0)
OC.11.2 CHARACTERIZATION OF INCIDENT CASES OF CANCER IN INFLAMMATORY BOWEL DISEASE PATIENTS: A PROSPECTIVE MULTICENTER CASE-CONTROL IG-IBD STUDY (2014) (0)
Recently recruited monocyte/macrophages and naive T-cells contribute to submucosal perivascular infiltrates in Crohn's disease (CD) (1995) (0)
TH17 Cells and IL-23 in Gut Inflammation (2011) (0)
HIGH INTERLEUKIN-17A (IL-17A) EXPRESSION IN CELIAC DISEASE MUCOSA (2009) (0)
Reply: To PMID 24813174. (2015) (0)
OC.06.2: ROLE OF INTERLEUKIN-21 IN THE GROWTH OF COLITIS-ASSOCIATED COLON CANCER (2011) (0)
5 OP Activated STAT4 and a functional role for IL-12 in peyer's patches explains the TH1 dominated responses of human gut-associated lymphoid tissue (2002) (0)
EFFECTS OF ANTI-TNFα TREATMENTS ON EACH SINGLE VARIABLE OF THE CROHN'S DISEASE ACTIVITY INDEX (CDAI): A PROSPECTIVE LONGITUDINAL STUDY (2009) (0)
P190 Small intestine contrast ultrasonography (SICUS) and CT-enteroclysis in the assessment of Crohn's disease lesions (2012) (0)
BIOLOGIC THERAPIES AND SUB-OBSTRUCTIVE SYMPTOMS IN CROHN'S DISEASE: PROSPECTIVE LONGITUDINAL STUDY (2009) (0)
P.02.9 INCIDENT CASES OF CANCER IN IBD: CLINICAL CHARACTERISTICS OF IBD VS IMMUNOMODULATORS IN A PROSPECTIVE MULTICENTER CASE-CONTROL STUDY (2013) (0)
Microenvironment and Immunology Smad 7 Expression in T cells Prevents Colitis-Associated Cancer (2011) (0)
P.1.314: FISTULIZING PATTERN AND YOUNG AGE AT THE DIAGNOSIS AS RISK FACTORS FOR CANCER MORE RELEVANT THAN IMMUNOMODULATORS IN CROHN'S DISEASE: A SINGLECENTER COHORT STUDY IN 1288 PATIENTS (2011) (0)
P058 Early Crohn's disease associates with a mixed Th cell response predominant accumulation not related with endoscopic recurrence (2012) (0)
W1535 C-Reactive Protein Levels for Predicting Early Recurrence After Ileo-Cecal Resection in Crohn's Disease. Preliminary Report of a Prospective Longitudinal Study (2009) (0)
Protective Effects of Timp-3 on Gut Inflammation (2011) (0)
OC1.04.1 AUTOCRINE REGULATION OF INTERLEUKIN-21 PRODUCTION IN HUMAN PERIPHERAL BLOOD AND INTESTINAL T LYMPHOCYTES (2008) (0)
PA.163 SMALL INTESTINE CONTRAST ULTRASONOGRAPHY (SICUS) FOR DETECTING ASYMPTOMATIC SMALL BOWEL CROHN'S DISEASE: A FAMILY STUDY (2008) (0)
OC.09.7 INHIBITION OF THE MITOCHONDRIAL ATP SYNTHASE PROMOTES T CELL APOPTOSIS AND SUPPRESSES INTESTINAL INFLAMMATION (2016) (0)
P.1.247: SAFETY AND EFFICACY OF ANTI-TNFS IN CROHN'S DISEASE PATIENTS: A SINGLE CENTER STUDY (2011) (0)
Su1135 Multidisciplinary Approach in IBD Patients With Arthralgias: Usefulness of a Combined Reumatologic and Gastroenterologic Assessment in a Prospective Study (2014) (0)
OC.06.1: INHIBITION OF COLITIS BY IL-25 ASSOCIATES WITH INDUCTION OF ALTERNATIVELY ACTIVATED MACROPHAGES (2011) (0)
THE EXPERIENCE OF PAIN IN INFLAMMATORY BOWEL DISEASE (2008) (0)
ADDITIONAL DIAGNOSTIC YIELD OF NARROW BAND IMAGING FOR THE SCREENING–SURVEILLANCE PROGRAM OF LONG-STANDING ULCERATIVE COLITIS: A PILOT PROSPECTIVE BACK-TO-BACK COLONOSCOPY STUDY (2009) (0)
P.149 HEPATOPROTECTIVE EFFECT OF INTERLEUKIN (IL-) 25 IN A MOUSE MODEL OF ACUTE LIVER INJURY (2010) (0)
Endoscopy personnel and Helicobacter pylori infection. (1999) (0)
Mo1160 In Vitro and In Vivo Knock-Down of Smad7 Inhibits Growth and Promotes Apoptosis of Colon Cancer Cells (2013) (0)
P292 Clinical characteristics of inflammatory bowel disease may influence the cancer risk when using immunomodulators: incident cases of cancer in a multicenter case-control study (2013) (0)
Suggestion against an oro-oral, route of transmission for Helicobacter pylori infection: A seroepidemiological study in a rural area (1998) (0)
OC.05.6 SMAD7 POSITIVELY REGULATES COLON CANCER CELL SURVIVAL (2014) (0)
Evidence against an autoimmune aetiology for inflammatory bowel diseases. (1992) (0)
P166 Predictive factors for anatomic extent of lesions in patients affected by ulcerative colitis (2014) (0)
FRI0191 IL17 Producing Non-T Cells in Patients with Enteropathic Spondyloarthropathy: The Association with Disease Activity (2015) (0)
Interleukin-21 regulates the T helper cell type 1 transcription factor T-bet in celiac disease mucosa (2006) (0)
P.1.33: 2-METHOXY-5-AMINO-N-HYDROXYBENZAMIDE SENSITIZES COLON CANCER (CC) CELLS TO TRAIL THROUGH MODULATION OF DEATH RECEPTOR (DR)5 AND SURVIVIN (2011) (0)
Presentation of the meeting (2010) (0)
S15 Aryl hydrocarbon receptor signaling protects mice from inflammatory bowel disease (2010) (0)
Related articles (2015) (0)
OC.12.3 FREQUENCY AND CAUSE OF PERSISTENT SYMPTOMS IN CELIAC DISEASE PATIENTS ON A LONG-TERM GLUTEN-FREE DIET (2014) (0)
20 PS Activation of signal transducer and activator for transcription in celiac disease (2002) (0)
OC.05.2 TH17-RELATED CYTOKINES AND EXCESSIVE ACTIVATION OF STAT3 SUSTAIN COLORECTAL CANCER CELL GROWTH (2014) (0)
FRI0222 Impact of a Multidisciplinary Approach in Enteropathic Spondiloarthritis: Usefulness of a Combined Assessment in Prevalence, Characteristics, Diagnostic Delay and Outcomes (2015) (0)
OC.09.4 EXPRESSION OF THE ACTIVATED FORM OF AMPK IS REDUCED IN IBD BUT SELECTIVE ACTIVATION OF THIS KINASE IS NOT SUFFICIENT TO REVERT INTESTINAL INFLAMMATION (2016) (0)
Perianal Crohn's Disease assessment: Technetium-99m HMPAO labelled leukocyte single photon emission computerised tomography (SPECT) versus magnetic resonance imaging (MRI) (2006) (0)
Fistulizing Pattern and Young Age at the Diagnosis as Risk Factors for Cancer in Crohn's Disease: A Single-Center Cohort Study Involving 1288 Inflammatory Bowel Disease Patients (2011) (0)
P.24 PATTERN OF CONCURRENT MEDICATION USE IN ITALIAN PATIENTS WITH NONVARICEAL UPPER GI BLEEDING (NVUGIB): RESULTS OF THE INTERNATIONAL “ENERGIB” STUDY (2010) (0)
OC.12.6 REGENERATING ISLET-DERIVED 3-ALPHA AS BIOMARKER FOR SMALL INTESTINAL DAMAGE AND ITS SIGNIFICANCE IN THE MANAGEMENT OF CELIAC DISEASE PATIENTS (2014) (0)
DOP066 Psoriasis phenotype in inflammatory bowel disease: a case-control prospective longitudinal study (2014) (0)
M1104 Evolution of the Lesions Related to Crohn's Disease Recurrence As Assessed By Ultrasonography: A Prospective Longitudinal Study (2009) (0)
P145 Small bowel capsule endoscopy for assessing the early postoperative recurrence of Crohn's disease: Correlation with the endoscopic score at 6 and 12 months in a prospective study (2014) (0)
OC.12.4 NATURAL COURSE OF CROHN'S DISEASE AFTER ILEOCOLONIC RESECTION: EARLY CROHN'S DISEASE ASSOCIATES WITH A MIXED TH CELL RESPONSE PREDOMINANT ACCUMULATION NOT RELATED WITH ENDOSCOPIC RECURRENCE (2012) (0)
P.05.2 DIMINISHED EXPRESSION OF SCAVENGER RECEPTORS ASSOCIATES WITH ACCUMULATION OF APOPTOTIC BODIES IN CELIAC DISEASE MUCOSA (2013) (0)
OC1.01.3 ASSESSMENT OF CROHN'S DISEASE RECURRENCE AFTER ILEO-COLONIC RESECTION: CORRELATION BETWEEN ENDOSCOPIC SCORE AND SONOGRAPHIC FINDINGS (2008) (0)
P.01.19 PSORIASIS PHENOTYPE IN INFLAMMATORY BOWEL DISEASE (2013) (0)
P371 Sonographic lesion index for Crohn's disease assesses small bowel damage after biologic therapy (2012) (0)
P227 Impact of small intestine contrast ultrasonography in the management of Crohn's disease patients (2013) (0)
P252 Correlation between severity of endoscopic lesions and clinical activity in a cohort of Crohn's disease patients followed up for 5 years after ileo-colonic resection (2014) (0)
4 P VSL-3 is a powerful inducer of NF-kB activation in human intestinal epithelial cells (2002) (0)
Transnasal upper gastrointestinal endoscopy with ultrathin XGIF-N160Y1 olympus prototype: A pilot study on accuracy and safety (2006) (0)
PA.152 TREATMENT WITH ANTI-TUMOR NECROSIS FACTOR ALPHA ANTIBODIES AND SUB-OBSTRUCTIVE SYMPTOMS IN CROHN'S DISEASE: PROSPECTIVE LONGITUDINAL STUDY (2008) (0)
Leukocytapheresis using cellsorba (LCAP) in patients with ulcerative colitis (2006) (0)
P.03.6 CD163-EXPRESSING MACROPHAGES WITH INFLAMMATORY PROPERTIES INFILTRATE HEAVILY THE GUT MUCOSA OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE (2013) (0)
W1047 Bowel Ultrasonography for Timely Diagnosis of Intestinal Acute Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation (2009) (0)
Sa1701 Smad7-Mediated Suppression of IL-17A in CD4+ T Cells Prevents Early but Not Late Stage Colorectal Cancer Development (2013) (0)
49 P Virtual colonoscopy for the assessment of postoperative recurrence in Crohn's disease (2002) (0)
OC.04.1 SMAD7 KNOCKDOWN IN COLON CANCER CELLS ACTIVATES PROTEIN KINASE RNA-ASSOCIATED EIF2-ALPHA PATHWAY THEREBY LEADING TO CELL DEATH (2016) (0)
9 PS Defective TGF-beta activity contributes to the sustained NF-kB activation in chronic intestinal inflammation (2002) (0)
COLORECTAL CANCER SCREENING BY COLONOSCOPY: EXPERIENCE IN HIGH AND LOW RISK POPULATION (2009) (0)
M1157 Luminal vs Extraluminal Findings Compatible with Crohn's Disease Recurrence: Prospective Longitudinal Study 3 Years After Surgery (2009) (0)
further consideration, apart from the relationships of pCTL frequencies reported here. (1999) (0)
P.103 2-METHOXY-5-AMINO-N-HYDROXYBENZAMIDE, A NOVEL DERIVATIVE OF 5-AMINOSALICYLIC ACID, INDUCES DR4 AND DR5 AND ENHANCES TRAIL-INDUCED APOPTOSIS IN COLON CANCER (CC) CELLS (2010) (0)
P.04.4 SCREENING FOR MELANOMA AND NON MELANOMA SKIN CANCER IN IBD PATIENTS BEFORE TREATMENT WITH THIOPURINES AND ANTI-TNFs: A PROSPECTIVE COHORT STUDY (2014) (0)
Chain in Crohn's Disease 2 b Up-Regulation of the IL-12 Receptor (2000) (0)
P184 NF-kB Controls the Expression of Flip, An Inhibitor of Fas-Mediated Apoptosis, In Crohn's Disease Lymphocytes (2007) (0)
OC.02.4 CLINICAL OUTCOMES OF PATIENTS WITH NONVARICEAL UPPER GI BLEEDING (NVUGIB): ITALIAN RESULTS OF THE INTERNATIONAL “ENERGIB” STUDY (2010) (0)
P.15.10 CORRELATION BETWEEN SEVERITY OF ENDOSCOPIC LESIONS AND CLINICAL ACTIVITY IN A COHORT OF CROHN'S DISEASE PATIENTS FOLLOWED UP FOR 5 YEARS AFTER ILEO-COLONIC RESECTION (2014) (0)
517 T Cell-Specific Smad7 Over-Expression Reduces Regulatory T Cell-Mediated Control of Colitis (2008) (0)
University of Birmingham Real-time Interobserver Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn's Disease (2018) (0)
P.108 EUS ACCURACY IN RESTAGING RECTAL CANCER AFTER NEOADJUVANT CHEMORADIOTHERAPY: A PRELIMINARY REPORT (2010) (0)
PA.119 COLORECTAL CANCER SCREENING: ARE WE DOING ENOUGH? ONE YEAR SINGLE CENTER EXPERIENCE IN HIGH AND LOW RISK POPULATION (2008) (0)
Mo1244 Psoriasis Phenotype in Inflammatory Bowel Disease (2013) (0)
Motility of Intestinal Macrophages in Patients with Colorectal Carcinoma (CA) (1984) (0)
W1109 In Vitro and In Vivo Inhibition of Colorectal Cancer (CRC) Cell Growth By 2-14, a Novel Derivative of 5-Aminosalycilic Acid (2008) (0)
Malabsorbtion syndrome and chronic diarrhoea [Il malassorbimento e la diarrea cronica] (2006) (0)
P243 - Small intestine contrast ultrasonography for detecting asymptomatic small bowel Crohn's disease lesions: a family study (2009) (0)
In uncomplicated gerd patient most of tipical sipmtoms is associated with proximal extent of acid reflux (2001) (0)
OC.03.1 SMAD7 EXPRESSION AND REGULATION BY SIRT1 IN INFLAMMATORY BOWEL DISEASES (2014) (0)
A functional role of interleukin-21 (IL-21) in promoting matrix metalloproteinases synthesis by gastric epithelial cells during helicobacter pylori infection (2006) (0)
M2A Patency Capsule Prior to Video Capsule Endoscopy in Patients with Morphological Small Bowel Strictures (2004) (0)
Reply: To PMID 25785968. (2015) (0)
P183 Treatment with Anti-Tumor Necrosis Factor Alpha Antibodies and Sub-Obstructive Symptoms in Crohn's Disease: Prospective Longitudinal Study (2008) (0)
Mo1201 Colon Cancer in IBD Patients Treated or Untreated With Anti-TNFs: A Retrospetive Matched-Pair Study in a 13 Years Follow Up (2014) (0)
The Uncertain Role of Immunomodulator Maintenance After Cessation of Anti-Tumor Necrosis Factor a Therapy (2015) (0)
OC.02.3 SMAD7 KNOCKDOWN RESTORES ARYL HYDROCARBON RECEPTOR EXPRESSION AND PROTECTIVE SIGNALS IN INFLAMMATORY BOWEL DISEASE (2016) (0)
We acknowledge patients and their families, and thank family recruitment doctors: (2001) (0)
2-Methoxy-5-Amino-N-Hydroxybenzamide Sensitizes Colon Cancer (CC) Cells to TRAIL-Mediated Apoptosis Through Modulation of Death Receptor (DR)5 and Survivin (2011) (0)
New biologic therapies in patients with Inflammatory Bowel Disease [Nuovi farmaci biologici nelle Malattie Infiammatorie Croniche Intestinali] (2008) (0)
I-123 INTERLEUKIN-2 (I-123-IL-2) SCINTIGRAPHY FOR IN-VIVO DETECTION OF GUT LYMPHOCYTE INFILTRATION IN CROHNS-DISEASE (CD) (1995) (0)
57 OP Tropomyosin isoform 5 expression in gastric intestinal metaplasia: A novel subclinical marker of intestinal-type gastric cancer? (2002) (0)
High seroprevalence of Helicobacter pylori but not hepatitis A and Epstein-Barr virus in children with mental retardation: Implications for transmission pathway (2000) (0)
EVOLUTION OF THE LESIONS RELATED TO CROHN'S DISEASE RECURRENCE AS ASSESSED BY ULTRA-SONOGRAPHY: A PROSPECTIVE LONGITUDINAL STUDY (2009) (0)
P177 Ileocolonoscopy and small intestine contrast ultrasonography (SICUS) as predictors of clinical outcome after ileo-colonic resection for Crohn's disease: A prospective study at 5 years (2012) (0)
P.1.40: IL-21 PRODUCTION IS POSITIVELY REGULATED BY IL-15 IN CELIAC DISEASE MUCOSA (2011) (0)
NEWLY DIAGNOSED NEOPLASIA IN A COHORT OF CROHN'S DISEASE PATIENTS TREATED OR UNTREATED WITH INFLIXIMAB FOLLOWED UP IN THE LONG TERM: A MULTICENTER MATCHED-PAIR STUDY (2009) (0)
OC.12.3 INCIDENT CANCER IN INFLAMMATORY BOWEL DISEASE IN A PROSPECTIVE MULTICENTER NESTED CASE-CONTROL IG-IBD STUDY (2018) (0)
Development of a Quantitative Sonographic Lesion Index for Small Bowel Crohn's Disease (2011) (0)
P.16.10 UTILITY OF EUS-FNA ON DIAGNOSTIC WORK UP AND THERAPEUTIC DECISION IN PATIENTS WITH SUSPICION OF MALIGNANT LESIONS (2013) (0)
OC.11.1 INFLAMMATORY BOWEL DISEASE PHENOTYPE AS RISK FACTOR FOR CANCER IN A PROSPECTIVE MULTICENTER NESTED CASE-CONTROL IG-IBD STUDY (2016) (0)
P.01.8 ARYL HYDROCARBON RECEPTOR-DRIVEN SIGNALS DOWN-REGULATE INTESTINAL FIBROSIS (2014) (0)
S1112 Newly Diagnosed Neoplasia in a Cohort of Crohn's Disease Patients Treated or Untreated with Infliximab Followed Up in the Long Term: A Multicenter Matched-Pair Study (2009) (0)
Chronic diarrhoea: Differential diagnosis [Diarrea cronica: Diagnosi differenziale] (2006) (0)
Pathogenetic mechanisms of inflammatory bowel disease. (1995) (0)
T-Bet and GATA-3 expression correlates with the predominant Th1 cell polarization in active celiac disease mucosa (2003) (0)
High Expression of ADAM19, a Sheddase for TNF-Alpha, in the Mucosa of Patients With Inflammatory Bowel Disease (IBD) (2011) (0)
Su1924 Small Bowel Capsule Endoscopy for Assessing Early Postoperative Recurrence of Crohn's Disease: A Prospective Longitudinal Study (2012) (0)
P.04.11 SPECIFIC PSORIASIS PHENOTYPES ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE: A MONOCENTRIC PROSPECTIVE CASE-CONTROL STUDY (2014) (0)
OC.01.4 EUS PREDICTIVE FACTORS OF RECURRENCE IN PATIENTS WITH LOCAL ADVANCED RECTAL CANCER (2016) (0)
OC3.02.1 HELICOBACTER PYLORI INFECTION ASSOCIATES WITH A MUCOSAL DOWN-REGULATION OF GHRELIN, NEGATIVE REGULATOR OF TH1 CELL RESPONSES (2008) (0)
M1787 Interleukin-25 Production is Differently Regulated by TNF-α and TGF-β1 in the Human Gut (2010) (0)
T1337 Biologic Therapies, Thiopurines and Cancer in Inflammatory Bowel Disease: A Single-Center Cohort Study Involving 1118 Patients (2010) (0)
P161 - Newly diagnosed neoplasia in a cohort of Crohn's disease patients treated or untreated with infliximab followed up in the long term: a multicenter matched-pair study (2009) (0)
P.02.13 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS (IPMNS): RESULTS OF A THREE-YEAR FOLLOW-UP STUDY (2016) (0)
P.01.8 SMALL BOWEL CAPSULE ENDOSCOPY FOR ASSESSING EARLY POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE: A PROSPECTIVE LONGITUDINAL STUDY (2012) (0)
P117 Perianal Crohn's Disease Assessment: Magnetic Resonance Imaging, Endoscopic Ultrasound, Examination under Anaesthesia (2008) (0)
P.16.12 SMALL INTESTINE CONTRAST ULTRASONOGRAPHY (SICUS) AND CT-ENTEROCLYSIS IN THE ASSESSMENT OF CROHN'S DISEASE LESIONS (2012) (0)
P.59 HIGH IFN-GAMMA EXPRESSION IS REQUIRED FOR TUMOR PROTECTION IN A MODEL OF COLITIS-ASSOCIATED COLORECTAL CANCER (2010) (0)
Sa1281 Asymptomatic Small Bowel Crohn's Disease: A Family Study (2012) (0)
Cancer in Infliximab treated or untreated Crohn’s disease patients: a 2 years longer follow up from a multicenter matched-pair study.. (2007) (0)
W1259 Adalimumab vs Infliximab Clinical Comparision: Longitudinal Study (2010) (0)
P.14.9 JEJUNAL CROHN'S DISEASE: CHARACTERISTICS, OUTCOME, NEED OF SURGERY AND IMMUNOMODULATORS IN A RETROSPECTIVE SINGLE-CENTER STUDY (2016) (0)
OC.12.4 INNATE LYMPHOID CELLS ARE INCREASED IN CELIAC DISEASE INTESTINAL MUCOSA AND HAVE A PATHOGENIC ROLE IN A MOUSE MODEL OF SMALL INTESTINE ATROPHY (2014) (0)
P532 Colon cancer in IBD patients treated or untreated with anti-TNFs: A retrospective matched-pair study in a 13 years follow up (2014) (0)
P.16.3 LEARNING CURVE FOR ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION (EUS-FNA) IN DIAGNOSIS OF ABDOMINAL AND MEDIASTINAL MASS (2013) (0)
P289 Colon cancer and colonic dysplasia in ulcerative colitis and Crohn's colitis: a single center cohort study (2013) (0)
Preface (2003) (0)
PA.164 CAPSULE ENDOSCOPY (CE) AND PROXIMAL SMALL BOWEL (SB) LESIONS IN PATIENTS WITH CROHN'S DISEASE (CD) (2008) (0)
P.02.16 ASSESSMENT OF BIOELECTRICAL IMPEDANCE PHASE ANGLE IN CROHN'S DISEASE PATIENTS (2013) (0)
PA.224 DOES BOWEL CLEANSING INFLUENCE THE EFFICACY OF URGENT COLONOSCOPY IN FINDING AND TREATING THE SOURCE OF LOWER GASTROINTESTINAL BLEEDING (2008) (0)
The production of interferon-gamma in human lamina propria T cells is regulated by interleukin (IL)-12, IL-7 and IL-15 (1998) (0)
P.1.27: THE REGULATORY CD163-POSITIVE MACROPHAGES INFILTRATE MASSIVELY THE INFLAMED GUT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES (2011) (0)
OC1.04.4 T CELL-SPECIFIC SMAD7 OVER-EXPRESSION REDUCES REGULATORY T CELL-MEDIATED CONTROL OF COLITIS (2008) (0)
P204 Small bowel capsule endoscopy in Crohn's disease: Detection of upper gastrointestinal lesions, impact rate, gastric and small bowel transit times in a tertiary referral center (2012) (0)
880 Accuracy of Small Intestine Contrast Ultrasonography Compared to Magnetic Resonance Enterography in Characterizing Lesions in Patients With Crohn's Disease (2014) (0)
Hepatitis virus infections in inflammatory bowel disease: A multicenter GISC study (2000) (0)
Molecular targets of mesalazine in colorectal cancer (2008) (0)
[Crohn disease: etiopathogenesis]. (1994) (0)
Additional Diagnostic Yield of Narrow Band Imaging for the Screening-Surveillance Program of Long-Standing Ulcerative Colitis: A Pilot Prospective Back-to-Back Colonoscopy Study (2009) (0)
Preface (2003) (0)
Mo1159 Contrast Enhanced Ultrasound as a Point-of-Care Technique in Complicated Crohn's Disease Patients (2014) (0)
Ex-vivo autoradiography and facs-scan analysis demonstration of a specific binding between IL2-receptor positive cells in Crohn's disease gut and 123I-interleukin-2 injected in vivo (1998) (0)
“ INTERLEUKIN-21 CONTROLS INFLAMMATORY PATHWAYS IN IBD (2007) (0)
Suggestions that gluten sensitivity is not a common feature of unclassified neurological disorders (1998) (0)
Newly diagnosed neoplasia in Crohn's Disease patients treated with infliximab: A 1 year longer follow up from a multicenter matched-pair study (2006) (0)
P.06.26 STEROID SPARING WITH ADALIMUMAB IN CROHN'S DISEASE PATIENTS: A REAL-LIFE EXPERIENCE IN A TERTIARY REFERRAL CENTER (2014) (0)
In Crohn's Disease Colonic Mucins Are Expressed in the Established Ileal Lesions at Surgery While Ileal Mucins Are Mainly Expressed in the Early Ileal Recurrence: A Prospective Longitudinal Study (2011) (0)
Aryl hydrocarbon receptor and colitis (2013) (0)
50 P Anti-COX2 treatment in patients with inflammatory bowel (2002) (0)
Is it always necessary to treat CD patients? (2008) (0)
OC.12.2 REFRACTORY CELIAC DISEASE-RELATED IMMUNE RESPONSE IS ASSOCIATED WITH HIGH TNF-ALPHA BUT NOT TH1-TYPE CYTOKINES (2013) (0)
OC.06.6 SONOGRAPHIC LESION INDEX FOR CROHN'S DISEASE ASSESSES SMALL BOWEL DAMAGE AFTER BIOLOGIC THERAPY (2012) (0)
P288 Accuracy of small intestine contrast ultrasonography compared to magnetic resonance enterography in characterizing lesions in patients with Crohn's disease (2014) (0)
Subject Index Vol. 33, Suppl. 1, 2015 (2015) (0)
Interleukin-12 receptor B2, a crucial component in the IL-12 Th1 response, is up-regulated in Crohn's disease (2000) (0)
S1219 Assessment of Crohn's Disease Recurrence After Ileo-Colonic Resection: Correlation Between Endoscopic Score and Sonographic Findings (2008) (0)
Expression of Th1 but not Th2 cytokine mRNA is enhanced in gastric mucosa of Helicobacter pylori infected children (2000) (0)
Human lamina propria T lymphocytes (T-LPL) do not proliferate in response to interleukin (IL)-12: Relation to defective IL-12 receptor β1 subunit expression (1998) (0)
PC.01.2 SMAD7 SUSTAINS COLON CANCER CELL GROWTH BY MODULATING PP1 AND EIF2-ALPHA TO REGULATE CDC25A (2014) (0)
Solitary juvenile polyp of the stomach. (1986) (0)
Transnasal gastroscopy without sedation versus transoral gastroscopy under sedation: A randomised prospective study on accuracy, acceptability, feasibility and safety (2006) (0)
P.02.12 COLON CANCER AND COLONIC DYSPLASIA IN ULCERATIVE COLITIS AND CROHN'S COLITIS: A SINGLE CENTER COHORT STUDY (2013) (0)
The HS1, 2A enhancer allele 2 shows an increased frequency in patients with Crohn's Disease (2006) (0)
Formation of granulomata in crohns disease relates to the motility of intestinal macrophages (1985) (0)
V1.1.5 EARLY SMALL AMPULLA CANCER EUS DETECTED AND STAGED (CASE REPORT) (2008) (0)
P352 Screening for melanoma and non melanoma skin cancer in IBD patients before treatment with thiopurines and anti-TNFs: A prospective cohort study (2014) (0)
P.05.5 COLON CANCER IN IBD PATIENTS TREATED OR UNTREATED WITH ANTI-TNFS: A RETROSPECTIVE MATCHED-PAIR STUDY IN A 13 YEARS FOLLOW UP (2014) (0)
P183 Multidisciplinary approach in IBD patients with arthralgias: usefulness of a combined rheumatologic and gastroenterologic assessment in a prospective study (2014) (0)
P077 - Evolution of the lesions related to Crohn's disease recurrence as assessed by ultrasonography: a prospective longitudinal study (2009) (0)
OC.08.6 2-METHOXY-5-AMINO-N-HYDROXYBENZAMIDE, A DERIVATIVE OF MESALAMINE, INHIBITS COLON CANCER CELL GROWTH THROUGH CYCLOOXYGENASE-2-DEPENDENT AND -INDEPENDENT MECHANISMS (2012) (0)
New Biologic Drugs for Ulcerative Colitis (2011) (0)
Tu1253 Regenerating Islet-Derived 3-Alpha As Biomarker for Small Intestinal Damage and Its Significance in the Management of Celiac Disease Patients (2014) (0)
M1956 High IFN-Gamma Expression is Required for Tumor Protection in a Model of Colitis-Associated Colorectal Cancer (2010) (0)
DETECTION OF L-DNA IN STOOL SAMPLES, USING DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (DHPLC): A NON INVASIVE TOOL FOR THE DIAGNOSIS OF COLORECTAL CANCER. PRELIMINARY REPORT (2009) (0)
P.1.134: CONTRAST-ENHANCED ULTRASONOGRAPHY IN EARLY ASSESSMENT OF THE EFFICACY OF CHEMOTERAPY IN PATIENTS WITH LIVER METATASIS: A PRELIMINARY REPORT (2011) (0)
OC.10.5 IN VITRO AND IN VIVO KNOCK-DOWN OF SMAD7 INHIBITS GROWTH AND PROMOTES APOPTOSIS OF COLON CANCER CELLS (2013) (0)
52 Smad7 Expression in T Cells Protects from Colitis-Associated Colorectal Cancer (2009) (0)
W1154 EUS Accuracy in Restaging Rectal Cancer After Neoadjuvant Chemoradiotherapy: A Preliminary Report (2010) (0)
P254 Contrast enhanced ultrasound as a point-of-care technique in complicated Crohn's disease patients (2014) (0)
PC.01.3 COLITIS-ASSOCIATED COLORECTAL CANCER INDUCES PHENOTYPE INSTABILITY AND EFFECTOR FUNCTIONS IN TUMOR-INFILTRATING REGULATORY T CELLS (2014) (0)
P440 Macrocytic anemia secondary to sulphasalazine in patients affected by ulcerative colitis and Crohn's colitis: a real issue? (2013) (0)
P-0110 The Influence of Prognostic Factors on Survival in Patients with Advanced Pancreatic Cancer Evaluated in not Referred Centre (2012) (0)
2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms. (2012) (0)
Su1266 Characterization of Incident Cases of Cancer in Inflammatory Bowel Disease: A Prospective Multicenter Nested Case-Control IG-IBD Study (2015) (0)
Tu1240 Colonic Phenotype of the Ileum in Crohn's Disease: Low Prevalence After Ileal Resection in a Prospective Longitudinal Study (2012) (0)
Human T Lymphocytes Autocrine Regulation of IL-21 Production in MacDonald (2008) (0)
INTERLEUKIN (IL)-12 RECEPTOR β2 SUBUNIT EXPRESSION IS UP-REGULATED IN CROHN'S DISEASE: (1999) (0)
Sa1730 Aryl Hydrocarbon Receptor-Driven Signals Down-Regulate Intestinal Fibrosis (2014) (0)
P.1.219: IN CROHN'S DISEASE COLONIC MUCINS ARE EXPRESSED IN THE ESTABLISHED ILEAL LESIONS AT SURGERY WHILE ILEAL MUCINS ARE MAINLY EXPRESSED IN THE EARLY POSTOPERATIVE RECURRENCE: A PROSPECTIVE LONGITUDINAL STUDY (2011) (0)
Mo1264 Clinical Characteristics of Inflammatory Bowel Disease May Influence the Cancer Risk When Using Immunomodulators: Incident Cases of Cancer in a Multicenter Case-Control Study (2013) (0)
OC.05.7: PROTECTIVE EFFECTS OF TIMP-3 ON GUT INFLAMMATION (2011) (0)
W1170 Effects of Anti-TNFA Treatments On Each Single Variable of the Crohn's Disease Activity Index (CDAI): A Prospective Longitudinal Study (2009) (0)
P051 Wireless Capsule Endoscopy Versus Small Intestine Contrast Ultrasonography For Assessing The Postopertive Recurrence of Crohn's Disease: A Prospective Longitudinal Study (2007) (0)
OC.06.8 PREVALENCE OF CRC AND ADVANCED ADENOMA IN FIRST-DEGREE RELATIVES OF CRC PATIENTS: RESULTS OF A 3-YEARS STUDY (2010) (0)
OC.12.6 CHARACTERIZATION OF INFLAMMATORY CYTOKINE RESPONSE IN HUMAN SPORADIC COLORECTAL CANCER (2013) (0)
21 P Enhanced expression of interferon regulatory factor-1 in celiac disease mucosa (2002) (0)
P.08.9 MACROCYTIC ANEMIA SECONDARY TO SULPHASALAZINE IN PATIENTS AFFECTED BY ULCERATIVE COLITIS AND CROHN'S COLITIS: IS IT A REAL ISSUE? (2013) (0)
Commentary: interferon-gamma for treating Crohn's disease: do we know what is helpful and what is harmful? (1997) (0)
CD3 and CD68 positive cells accumulate in the neo-terminal ileum of Crohn’s disease patients. (2013) (0)
P168 - Effects of anti-TNF-α treatments on each single variable of the Crohn's Disease Activity Index (CDAI): a prospective longitudinal study (2009) (0)
P.181 ENDOSCOPIC TREATMENT OF NONVARICEAL UPPER GI BLEEDING (NVUGIB): ITALIAN RESULTS OF THE INTERNATIONAL “ENERGIB” STUDY (2010) (0)
Metastatic Crohn's disease (CD) or annular elastolytic granuloma of the forehead? (2000) (0)
23 Autocrine Regulation of Interleukin-21 Production in Human Peripheral Blood and Intestinal T Lymphocytes (2008) (0)
OC3.06.5 ROLE OF CIRCULATING TUMOUR MARKER CA19.9 AND ANTIANGIOGENIC THERAPY WITH BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER ON FIRST LINE SYSTEMIC TREATMENT (2008) (0)
P.1.101: LACTOBACILLI CASEI (LC) REDUCE TRYPSIN EXPRESSION IN INTESTINAL CELLS THEREBY LEADING TO INACTIVATION OF PAR2 AND UP-REGULATION OF ZO-1 (2011) (0)
Serum immunomodulatory factors in gastrointestinal diseases. A 30‐50‐kD serum fraction in Crohn's disease capable of modulating lymphocyte activation (1991) (0)
P.53 ARYL HYDROCARBON RECEPTOR SIGNALING PROTECTS MICE FROM INFLAMMATORY BOWEL DISEASE (2010) (0)
Oral presentationDifferent patterns of acid reflux extent in the esophageal body in healthy volunteers and in endoscopy-negative GERD patients (2001) (0)
Sa1783 Cd163-Expressing Macrophages With Inflammatory Properties Infiltrate Heavily the Gut Mucosa of Patients With Inflammatory Bowel Disease (2013) (0)
P.1.262: DEVELOPMENT OF A QUANTITATIVE SONOGRAPHIC LESION INDEX FOR SMALL BOWEL CROHN'S DISEASE (2011) (0)
P579 Bowel damage after biological therapy assessed by Sonographic Lesion Index for Crohn's disease (2013) (0)
Phase I Clinical Trial of Smad7 Knockdown Using Antisense Oligonucleotide in Patients With Active Crohnʼns Disease (2012) (0)
CT-ENTEROGRAPHY VS SMALL INTESTINE CONTRAST ULTRASONOGRAPHY IN ASSESSING ILEAL LESIONS IN CROHN'S DISEASE: A PROSPECTIVE LONGITUDINAL STUDY IN PATIENTS UNDERGOING SURGERY (2009) (0)
Activation ofperipheral blood andintestinal lamina propria lymphocytes inCrohn's disease. Invivo state ofactivation andinvitro responsetostimulation as defined bytheexpression ofearly activation antigens (1987) (0)
Technetium-99m labelled leukocyte single photon emission computerised tomography (SPECT) for Crohn's disease assessment (2004) (0)
W1267 Thiopurine-Induced Peripheral T Cells Apoptosis and Drug Response in Patients With Crohn's Disease (2010) (0)
Interleukin (IL) 17 activates mitogen-activated protein kinases leading to IL-8 production in gastric epithelial cells (2003) (0)
OC1.04.2 REGULATION OF GUT INFLAMMATION AND TH17 CELL RESPONSE BY INTERLEUKIN-21 (2008) (0)
P.95 DEVELOPMENT OF COLONIC METAPLASIA IN THE NEO-TERMINAL ILEUM OF CROHN'S DISEASE PATIENTS AFTER ILEO-COLONIC RESECTION AND RECURRENCE: A PROSPECTIVE LONGITUDINAL STUDY (2010) (0)
P270 Contrast enhanced ultrasound as a valuable tool in complicated Crohn's disease patients (2013) (0)
P157 Comparison between Techniques Providing a Different View of the Peri-Anastomotic Area (Luminal vs Extraluminal) in Assessing Crohn's Disease Recurrence: A Prospective Longitudinal Study (2008) (0)
P.13.10 SMAD7-MEDIATED SUPPRESSION OF IL-17A IN CD4+ T CELLS PREVENTS EARLY BUT NOT LATE STAGE COLORECTAL CANCER DEVELOPMENT (2013) (0)
Sa2028 Inter-Observer Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn's Disease (2016) (0)
Chain in Crohn's Disease Up-Regulation of the IL-12 Receptor (2000) (0)
Regulation of Matrix Metalloproteinases Synthesis by Interleukin-21 in Human Intestinal Fibroblasts (2006) (0)
P.04.6 ACCURACY OF SMALL INTESTINE CONTRAST ULTRASONOGRAPHY COMPARED TO MAGNETIC RESONANCE ENTEROGRAPHY IN CHARACTERIZING LESIONS IN PATIENTS WITH CROHN'S DISEASE (2014) (0)
P.06.5 HIGH SMAD7 IN REFRACTORY CELIAC DISEASE SUSTAINS INFLAMMATORY CYTOKINE RESPONSE (2016) (0)
Mo1192 Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study (2014) (0)
Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease (2018) (0)
P.195 CONTRAST ENHANCED ENDOSCOPIC ULTRASOSONOGRAPHY (CE-AEUS) FOR ASSESSING PERIANAL DISEASE: PRELIMINARY STUDY (2010) (0)
Malattia di Crohn. In: Malattie del canale digerente. Gasbarrini G, Morelli A. (2009) (0)
The Dual Role of Myeloid- Derived Suppressor Cells in Liver Pathologies (2014) (0)
S1215 Capsule Endoscopy and Proximal Small Bowel Lesions in Patients with Crohn's Disease (2008) (0)
One-week lansoprazole (LAN) based triple therapy is more effective than 2-week ranitidine bismuth citrate (RBC) based dual therapy in Hericobacter pylori-infected patients with duodenal ulcer (DU): A multicenter, randomized, double-dummy study (2000) (0)
P.184 HEMODYNAMIC INSTABILITY AFFECTS CLINICAL OUTCOMES IN PATIENTS WITH NONVARICEAL UPPER GI BLEEDING (NVUGIB): ITALIAN RESULTS OF THE INTERNATIONAL “ENERGIB” STUDY (2010) (0)
Mo1667 Colitis-Associated Colorectal Cancer Induces Phenotype Instability and Effector Functions in Tumor-Infiltrating Regulatory T Cells (2014) (0)
PO-2: 99Tcm-HMPAO scintigraphy in the early detection of the recurrence of Crohnʼs disease (1997) (0)
Su1856 TH17-Related Cytokines and Excessive Activation of STAT3 Sustain Colorectal Cancer Cell Growth (2014) (0)
Lamina propria mononuclear cells (LPMC) apoptosis in relation to different activation pathways (1995) (0)
P.64 INTERLEUKIN-25 PRODUCTION IS DIFFERENTLY REGULATED BY TNF-α AND TGF-β1 IN THE HUMAN GUT (2010) (0)
OC3.06.9 IN VITRO AND IN VIVO INHIBITION OF COLORECTAL CANCER (CRC) CELL GROWTH BY 2-14, A NOVEL DERIVATIVE OF 5-AMINOSALYCILIC ACID (2008) (0)
Activation of MAP-kinases and increased levels of interleukin 8 in ex vivo human gastric epithelial cells associates with Helicobacter pylori infection (2003) (0)
M1534 Surgery for Fistula-in-Ano in a Specialist Colorectal Unit: A Critical Appraisal (2009) (0)
9 P Interleukin 17 activates mitogen-activated protein kinases leading to interleukin 8 production in gastric epithelial cells (2002) (0)
P.174 DIAGNOSTIC ROLE OF CAPSULE ENDOSCOPY IN PATIENTS WITH SYMPTOMS HIGHLY COMPATIBLE WITH CROHN'S DISEASE (2009) (0)
INTERLEUKIN (IL)-25 INHIBITS IL-12 PRODUCTION AND TH1 CELL-DRIVEN INFLAMMATION IN THE GUT (2009) (0)
10 P Enhanced expression of TXK, a TEC kinase, in the mucosa of patients with inflammatory bowel disease (IBD) (2002) (0)
Different patterns of acid reflux extent in the esophageal body in healthy volunteers and in endoscopy-negative GERD patients (2001) (0)
High-resolution sonography of the bowel for timely diagnosis of intestinal acute graft versus host disease after allogenic hematopoietic stem cell transplantation (2006) (0)
LUMINAL VS EXTRALUMINAL FINDINGS COMPATIBLE WITH CROHN'S DISEASE RECURRENCE: PROSPECTIVE LONGITUDINAL STUDY 3 YEARS AFTER SURGERY (2009) (0)
W1144 Comparison Between Techniques Providing the Luminal vs Extraluminal Surface in Assessing Crohn's Disease Recurrence: A Prospective Longitudinal Study (2008) (0)
Usefulness of scintigraphy using 99mTc-EMPAO labelled granulocytes (PMN) as early indicator of postoperative asymptomatic recurrence in Crohn's disease (CD) (1995) (0)
P.15.8 CONTRAST ENHANCED ULTRASOUND AS A POINT-OF-CARE TECHNIQUE IN COMPLICATED CROHN'S DISEASE PATIENTS (2014) (0)
Cyclooxygenase-2 (Cox-2) independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid (5-ASA) (2006) (0)
LE-10. Immunopathogenesis of inflammatory bowel diseases (1997) (0)
[IBD: Crohn's disease]. (2016) (0)
in Crohn's Disease Bioactive IL-18 Expression Is Up-Regulated (1999) (0)
P.13.18 THE ENDOSCOPIC PERFORMANCE OF GASTROENTEROLOGY TRAINEES IN A TERTIARY GASTROINTESTINAL UNIT (2014) (0)
M1101 Diagnostic Role of Wireless Capsule Endoscopy in Patients with Symptoms Highly Compatible with Crohn's Disease (2009) (0)
P083 LOCAL INJECTION OF INFLIXIMAB IN CROHN'S DISEASE RECURRENCE: A PILOT PROSPECTIVE LONGITUDINAL STUDY IN THE LONG-TERM (2007) (0)
The enhanced Th1 response associates with a reduced GATA-3 expression in Helicobacter pylori-infected human gastric mucosa (2001) (0)
P.05.18 COLONIC PHENOTYPE OF THE ILEUM IN CROHN'S DISEASE: LOW PREVALENCE AFTER ILEAL RESECTION IN A PROSPECTIVE LONGITUDINAL STUDY (2012) (0)
P.02.1 DISEASE IMPACT OF ULCERATIVE COLITIS ON PATIENTS' PERCEPTION: AN ITALIAN SURVEY (2013) (0)
T1269 Diagnostic Role of Capsule Endoscopy in Patients With Symptoms Highly Compatible With Crohn's Disease (2010) (0)
P167 - Treatment with anti-tumor necrosis factor alpha antibodies and sub-obstructive symptoms in Crohn's disease: a prospective longitudinal study (2009) (0)
Status of Constitutive Activation and Transient Hyporeactivity of T-lymphocytes of Human Intestinal Mucosa (1993) (0)
SP-5. Radiolabelled interleukin-2 scintigraphy for imaging CD25+ mononuclear cells in chronic inflammation: Scintigraphic and autoradiographic results (1997) (0)
Blockade of interleukin (IL)-21 enhances CD3+T cell death in the gut of patients with inflammatory bowel disease (IBD) (2006) (0)
OC.11.5 BOWEL DAMAGE AFTER BIOLOGICAL THERAPY ASSESSED BY SONOGRAPHIC LESION INDEX FOR CROHN'S DISEASE (2013) (0)
OC.06.5: ANALYSIS OF CYTOKINE PATTERNS IN EARLY RECURRENCE OF CROHN'S DISEASE (2011) (0)
ROLE OF SMALL INTESTINE CONTRAST ULTRASONOGRAPHY IN CELIAC DISEASE (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Francesco Pallone?

Francesco Pallone is affiliated with the following schools:

University of Oxford

Francesco Pallone's Academic­Influence.com Rankings

Why Is Francesco Pallone Influential?

Francesco Pallone's Published Works

Published Works

What Schools Are Affiliated With Francesco Pallone?

Francesco Pallone's AcademicInfluence.com Rankings